Impact of High‐Deductible Health Plans on Health Care Utilization and Costs

Abstract

Background. High-deductible health plans (HDHPs) are of high interest to employers, policy makers, and insurers because of potential benefits and risks of this fundamentally new coverage model. Objective. To investigate the impact of HDHPs on health care utilization and costs in a heterogeneous group of enrollees from a variety of individual and employer-based health plans. Data. Claims and member data from a major insurer and zip code-level census data. Study Design. Retrospective difference-in-differences analyses were used to examine the impact of HDHP plans. This analytical approach compared changes in utilization and expenditures over time (2007 versus 2005) across the two comparison groups (HDHP switchers versus matched PPO controls).Results. In two-part models, HDHP enrollment was associated with reduced emergency room use, increases in prescription medication use, and no change in overall outpatient expenditures. The impact of HDHPs on utilization differed by subgroup. Chronically ill enrollees and those who clearly had a choice of plans were more likely to increase utilization in specific categories after switching to an HDHP plan. Conclusions. Whether HDHPs are associated with lower costs is far from settled. Various subgroups of enrollees may choose HDHPs for different reasons and react differently to plan incentives.Key Words. High-deductible health plans, health insurance, health care utilization, chronically ill While enrollment in high-deductible health plans (HDHPs) is still a small fraction of the commercially insured market, the growth and experience of these plans are of high interest to employers, policy makers, and the health care industry in general because of the potential benefits and risks of this fundamentally new coverage model. A number of studies have sought to measure the impact of HDHP plans on health care utilization and cost, but various data limitations make further studies important. Using a large statewide database containing utilization data for a large group of enrollees across a

Comparison of Canadian public medication insurance plans and the impact on out-of-pocket costs

“…The limited published data reporting on cost-sharing mechanisms comes from the United States, where the relation between health insurance cost-sharing mechanisms, not medication insurance, is arguably different. 12,13 Our findings are particularly relevant given the current discussion in the academic literature regarding the need for a system of national pharmacare to replace the current patchwork system of pharmaceutical insurance in Canada.…”

Non–Emergency Department Interventions to Reduce ED Utilization: A Systematic Review

“…39,42 Three studies reported cost data with mixed results. 43–45 Five studies risk-adjusted data. 39,42,45,46,48 …”

What Strategies Do Physicians and Patients Discuss to Reduce Out-of-Pocket Costs? Analysis of Cost-Saving Strategies in 1,755 Outpatient Clinic Visits

“…1–3 This is occurring in the context of widespread increases in patient cost-sharing and rapid growth in enrollment in high-deductible health plans. 2,4–7 Consequently, Americans have more financial ‘skin in the game’ than ever before, and 59–80% of patients want to discuss healthcare costs with their physicians. 20,49–51 With nearly half of cost discussions involving cost-reducing strategies, our findings suggest that patient-physician discussion about out-of-pocket costs may be a helpful tool in addressing patients’ financial distress.…”

“…3 Key contributors to high out-of-pocket healthcare costs include increases in patient cost sharing, growth in high deductible healthcare plans, and increased use of expensive biologic or designer drugs. 2,4–7 In addition to depleting financial savings and damaging credit, high out-of-pocket medical costs negatively impact quality of life, medication adherence, and a variety of health outcomes. 3,6,8–12 …”